Clinical Trial

The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study

Study acronym: CANPCSS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study will investigate the long-term effects of nasopharyngeal carcinoma (NPC) and its associated therapies. A prospective and retrospective cohort study will be conducted through a multi-institutional collaboration. This project will study children and adolescents exposed to specific therapeutic modalities, including radiation, chemotherapy, and/or surgery, who are at increased risk of late-occurring adverse health outcomes. A group of sibling controls will be identified and data collected for comparison purposes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2018-08-16.
Trial Details
NCT Number NCT03637634
Lead Sponsor Hai-Qiang Mai,MD,PhD
Collaborators: Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangdong Provincial People's Hospital, First Affiliated Hospital of Jinan University, Nanfang Hospital, Southern Medical University, Affiliated Cancer Hospital of Shantou University Medical College, Zhanjiang Cancer Hospital, Zhongnan Hospital, First People's Hospital of Foshan, Dongguan People's Hospital, Fifth Affiliated Hospital, Sun Yat-Sen University, Shenzhen Second People's Hospital, Jiangmen Central Hospital, Yuebei People's Hospital, Hunan Cancer Hospital, Cancer Hospital of Guizhou Province, Fudan University, Fujian Cancer Hospital, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, The First Affiliated Hospital of Zhengzhou University, Zhejiang Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Shandong Cancer Hospital and Institute, Jiangsu Cancer Institute & Hospital, Jiangxi Provincial Cancer Hospital, Second Affiliated Hospital of Nanchang University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking University Cancer Hospital & Institute, Cancer Hospital of Guangxi Medical University, Tongji Hospital
Conditions NPC Patients
Enrollment 1,000 participants
Start Date 2018-09-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2018-08-28